Want to join the conversation?
Biopharma company $BXLT reported 4Q15 net income of $95MM or $0.14 per diluted share, including net after-tax special items of $292MM, mainly for intangible asset amortization and expenses associated with $BXLT's separation from $BAX. Adjusted net income was $387MM or $0.57 per diluted share versus outlook of $0.55-0.57 per diluted share.
Jeff Bezos, my inspiration next to Steve Jobs is going to review the Everything Store $AMZN's financial results today after hours. As an investor/user, I like Amazon Prime and it's success over several parts of the world. What's your take on Amazon?
Of all the Wall St firms out there, Goldman Sachs $GS is the most revered for the way they're run - hiring the best, highly competitive, a closely-knit peer group and making tons of profits for the shareholders. An interesting interview of its CEO Llyod Blankfein by Carlyle groups chief David Rubenstein
Great results from $TSLA, however the question remains if Tesla can continue to scale up to produce the cars in the quantity it promises. Model 3 numbers need to be in multiples of what they are producing right now. Wish them the best, will keep an eye as I am still not convinced that they can scale easily.
Watching $TSLA Oct 28th $215 Calls for possible entry